SYM Healthcare Co., Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

SYM Healthcare Co., Ltd. - overview

Established

2018

Location

Seoul, -, South Korea

Primary Industry

Healthcare IT

About

Based in Seoul, South Korea, and founded in 2018, SYM Healthcare Co. , Ltd. doing business as 4DEYE, operates as an integrated AI digital rehabilitation company that develops a real-time 4D data analysis-based motion evaluation solution. In July 2023, SYM Healthcare raised venture funding from CNTTech.


As of 2023, the company is led by its CEO Ahn Jung-hoon. SYM Healthcare Co. , Ltd. offers 4DEYE an AI musculoskeletal examination and rehabilitation solution to detect problems such as incorrect movements and postures, limited joint range, and incorrect movement compensation patterns through a multi-view image sensor-based AI musculoskeletal system and a sensing algorithm.


In addition, the company offers Medshare, an online rehabilitation education platform, that offers provides clinical education focusing on scientific evidence-based theory and improvement of treatment results.


Current Investors

AI Angel Club, Korea Venture Investment Corporation, CNT Tech

Primary Industry

Healthcare IT

Sub Industries

Healthcare IT, Chiropractic, Orthopedic & Physical Therapy, Monitoring Equipment, Medical Software

Website

www.symhealthcare.co.kr

Verticals

Artificial Intelligence, Artificial Intelligence, Big Data, Big Data, Big Data, HealthTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

SYM Healthcare Co., Ltd. - financials

Fiscal Year EndedDec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023
Revenue (USD)506,580,000400,614,000---
% Revenue Growth (YoY)-(20.9%)---
EBITDA (USD)-----
Operating Income (USD)(4,431,000)(131,781,000)---
Operating Margin(0.9%)(32.9%)---
% EBITDA Margin-----
NET Income (USD)(2,818,000)29,234,000---
% Net Margin(0.6%)7.3%---
GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.